in Newswire April 26, 2019

Boston Scientific Facing Securities Class Action After FDA Order to Stop Selling Transvaginal Mesh Products

by Corrado Rizzi

Last Updated on April 26, 2019

Klein v. Boston Scientific Corporation et al.

Filed: April 24, 2019 § 1:19-cv-03642

Boston Scientific faces a securities class action in the wake of the FDA's order for companies to stop selling dangerous transvaginal mesh products.

Last Updated on April 26, 2019 — 3:04 PM

Corrado Rizzi

Corrado Rizzi is the News Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.